Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gregory Fox

Professor of Respiratory Medicine

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (8)

Qingbin Li

Biostatistician

University of Sydney

AUSTRALIA

View details

James A. Seddon

Professor Extraordinary

Stellenbosch University

SOUTH AFRICA

View details

Amita Gupta

Professor of Medicine

Johns Hopkins University

UNITED STATES

View details

Peter Wark

Director of Cystic fibrosis and RES2

MONASH UNIVERSITY

AUSTRALIA

View details

Joel Negin

University of Sydney

AUSTRALIA

View details

Jay Achar

Karolinska Institutet

SWEDEN

View details

Hanif Esmail

University College London

UNITED KINGDOM

View details

Louis Grandjean

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Fox

Research Interests

Explore related searches

Articles (20)

The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis

Tuberculosis disease and infection among household contacts of bacteriologically confirmed vs unconfirmed tuberculosis in Cambodia: considerations for optimising contact investigation and preventive treatment

Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled Trial

Asymptomatic tuberculosis: new insights and knowledge gaps

Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis

Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era

Inhaled Ciclesonide for Community‐Based COVID‐19: A Placebo‐Controlled Randomised Trial

Molecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial

Pragmatic RE-AIM Evaluation of the Train-the-Trainer Vaccine Champions Program in Vietnam

Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam

Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva

Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis

Threshold cost of delivering preventive treatment for household contacts of people with multidrug-resistant TB

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis

Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice

Development and evaluation of a model to predict hypersensitivity reaction when using 3HP for TB infection

Acceptability of multidrug-resistant tuberculosis preventive treatment: a retrospective survey

Collaborators (8)

Qingbin Li

James A. Seddon

Amita Gupta

Peter Wark

Joel Negin

Jay Achar

Hanif Esmail

Louis Grandjean

Make your next move.